← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2013Last known activity
Oct 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 6 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Recent trials (6)
- NCT06585020CollaboratorPhase 2Oct 31, 2024
- NCT05373849Lead sponsorN/AMay 9, 2022
- NCT04529395Lead sponsorPhase 2Sep 18, 2020
- NCT02197221Overall official - principal investigatorPhase 3Jan 1, 2015
- NCT02176681Overall official - principal investigatorPhase 4Jun 1, 2014
- NCT01952223Overall official - principal investigatorPhase 3Sep 1, 2013
Details
- Last known activity
- Oct 31, 2024